The groundbreaking success of the copyright undeniably revolutionized the drug landscape, but betting in companies heavily reliant on off-patent versions presents a uncertain picture. Despite early profits were significant, the end of patents and the appearance website of less expensive alternatives have weakened the customer base. Consequently, a